The Lancet Gastroenterology & Hepatology in conversation with
Un pódcast de The Lancet Group
88 Episodo
-
Acute hepatitis C
Publicado: 8/3/2019 -
Epidemiology of chronic liver disease
Publicado: 8/2/2019 -
Viral hepatitis in migrant populations
Publicado: 7/12/2018 -
DAA treatment for hepatitis C among people who inject drugs
Publicado: 25/10/2018 -
Pancreatic cancer treatment
Publicado: 6/9/2018 -
UDCA Response Score
Publicado: 10/8/2018 -
Global prevalence, treatment, and prevention of hepatitis B virus infection
Publicado: 3/5/2018 -
Neoplasia detection in ulcerative colitis
Publicado: 6/4/2018 -
Functional dyspepsia
Publicado: 8/3/2018 -
Can DAA therapy for HCV reactivate HBV in coinfected patients?
Publicado: 8/2/2018 -
Oral immunotherapy: The Lancet Gastroenterology & Hepatology: February 2018
Publicado: 13/1/2018 -
Faecal transplantation: The Lancet Gastroenterology & Hepatology: Jan 2018
Publicado: 9/12/2017 -
PROTECT study: The Lancet Gastroenterology & Hepatology: December 2017
Publicado: 9/11/2017 -
Research priorities in Barrett's and GORD: The Lancet Gastroenterology & Hepatology: August 31, 2017
Publicado: 2/9/2017 -
Neurostimulation for abdominal pain: The Lancet Gastroenterology & Hepatology: August 18, 2017
Publicado: 19/8/2017 -
Oesophageal motility and solid meal tests: The Lancet Gastroenterology & Hepatology: August 2, 2017
Publicado: 3/8/2017 -
HALT-HCC score: The Lancet Gastroenterology & Hepatology: July 5, 2017
Publicado: 6/7/2017 -
Early intervention for alcohol-related liver disease: The Lancet Gastroenterology and Hepatology: June 7, 2017
Publicado: 8/6/2017 -
Stem cell transplantation in Crohn's: The Lancet Gastroenterology & Hepatology: May 5, 2017
Publicado: 5/5/2017 -
Colorectal cancer in sub-Saharan Africa: The Lancet Gastroenterology & Hepatology: April 5, 2017
Publicado: 6/4/2017
Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.
